SkyAI, Inc. (SKYA) stock
Close on Nov 11, 2026Market cap $127.66MP/E –Yield –
SkyAI, Inc. reported revenue of $192.78K for the twelve months to Sep 30, 2026. At the latest close the market valued the company at $127.66M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $127.66M
- P/E ratio
- –
- Price to sales
- 662.20
- Price to book
- 0.53
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $192.78K
- Net income
- -$207.25M
- EPS, diluted
- -$11.16
- Book value per share
- $3.36
- Diluted shares
- 72M
Trading
- Previous close
- $2.96
- Open
- $2.98
- Day's range
- $2.96 – $2.98
- Volume
- 349,651
- Average volume (20 days)
- 1,388,210
- Beta (5 years)
- 0.80
- 52-week range
- $0.91 – $4.02
- RSI (14 days)
- 73.7
- Volatility (1 year)
- 106.2%
- Relative volume
- 0.33×
- WACC
- 8.9%
Market cap history
Month-end market cap since 2022, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SKYA | S&P 500 | Difference | SKYA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +63.2% | -2.4% | +65.6 pts | ||
| 3 months | +156.0% | -1.2% | +157.2 pts | ||
| Year to date | +46.3% | +12.3% | +34.0 pts | ||
| 1 year | -18.4% | +12.4% | −30.9 pts | ||
| 3 years | -99.9% | +78.8% | −178.7 pts | -89.5% | +21.4% |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases SkyAI filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
About SkyAI
Finance Services
Sharps Technology, Inc. is a medical device sales and distribution company that specializes in marketing and distributing syringe products along with related drug-delivery systems. The enterprise previously designed and manufactured a range of conventional and safety syringes for specialty, clinical, and pharmaceutical uses, and it markets remaining inventory to healthcare providers, hospitals, medical supply organizations, and clinics. In addition to its medical distribution business, the company operates a digital asset treasury strategy dedicated to acquiring and holding Solana tokens, engaging in native staking and selective derivative transactions.
Company profile, executives and historySkyAI stock: common questions
What is SkyAI's stock price?
SKYA closed at $2.97 on Nov 11, 2026, up 0.34% on the day. Over the past 52 weeks it traded between $0.91 and $4.02.
What is SkyAI's market cap?
SkyAI was worth $127.66M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SKYA's P/E ratio?
SkyAI lost money over fiscal 2025 (diluted EPS -$11.16), so it has no meaningful P/E ratio.
How much revenue does SkyAI make?
SkyAI reported revenue of $192.78K for the twelve months to Sep 30, 2026.
Does SkyAI pay a dividend?
No. SkyAI has not paid a cash dividend over the last twelve months.
How has SKYA stock performed over the past year?
Including dividends, SKYA returned -18.4% over the past year, against +12.4% for the S&P 500.
Who are SkyAI's competitors?
Companies most similar to SkyAI by business, industry and size include MWAI, SGRX, HYPD, SSM, ALP.
See a number that looks wrong?